As a high-tech enterprise focusing on mass spectrometer R&D, production, sales and technical services, Hexin Instruments (stock code: 688622) demonstrated its brand advantages in the field of atmospheric environment monitoring and active expansion into new fields such as healthcare, laboratory analysis, and life science in the 2023 three-quarter report. The company's newly released quadrupole time-of-flight liquid-mass spectrometer (LC-QTOF 7000) further demonstrates its ability to continue to innovate in mass spectrometry technology.

In terms of assets and liabilities, Hexin Instrument's total assets increased by 12.57% from 972 million yuan at the end of the previous year to 1,094 million yuan at the end of the reporting period. Total liabilities rose from 461 million yuan at the end of the previous year to 632 million yuan, a significant increase. Accordingly, net assets declined, falling from $511 million at the end of the previous year to 462 million yuan. The balance ratio rose from 47.46% to 57.76%, reflecting an increase in the company's financial leverage.

In terms of profit, Hexin Instrument's revenue increased from 151 million yuan in the same period last year to 249 million yuan, an increase of 65.30%. Operating costs also increased accordingly, from 63.774 million yuan to 139 million yuan. Despite revenue growth, gross margin declined to 44.15% from 57.74% in the same period last year. In terms of net profit, the company lost money. Net profit attributable to shareholders of listed companies was -54.982 million yuan.

In terms of cash flow, net cash flow from operating activities was -607.763 million yuan, showing a negative increase compared with the same period last year. Despite this, the total cash inflow from operating activities increased from 244 million yuan in the same period last year to 279 million yuan, showing a certain increase in sales repayments.

In summary, Hexin Instruments showed strong revenue growth in the third quarter of 2023, mainly due to the normal development of the bidding process in the field of environmental monitoring and the smooth expansion of business in new fields such as medicine and laboratories. However, the company's net profit was affected by the increase in operating costs and the increase in the balance ratio also showed that the company was under certain financial pressure.

For investors, Hexin Instruments's innovative capabilities and business development prospects are worth paying attention to, but they also need to closely monitor changes in its financial situation and profitability. When considering investment decisions, the balance between a company's long-term development potential and short-term financial risk should be fully considered.

This article only represents the analyst himself or the analyst's judgment based on AI analysis. It cannot be used as an investment indicator, nor does it constitute any investment advice. The original purpose of this article is to help investors analyze and judge capital market data in the most intuitive and fastest way and from the most professional perspective.